tradingkey.logo
tradingkey.logo

Vivani Medical Inc

VANI
0.957USD
-0.123-11.37%
Market hours ETQuotes delayed by 15 min
1.38MMarket Cap
LossP/E TTM

Vivani Medical Inc

0.957
-0.123-11.37%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Vivani Medical Inc

Currency: USD Updated: 2026-03-27

Key Insights

Vivani Medical Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 114 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Vivani Medical Inc's Score

Industry at a Glance

Industry Ranking
114 / 208
Overall Ranking
270 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Vivani Medical Inc Highlights

StrengthsRisks
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Overvalued
The company’s latest PE is -2.39, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.84M shares, decreasing 13.62% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 97.98K shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
5.500
Target Price
+409.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Vivani Medical Inc is 5.69, ranking 190 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
5.69
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

4.92

Operational Efficiency

4.00

Growth Potential

4.55

Shareholder Returns

5.00

Vivani Medical Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Vivani Medical Inc is 7.34, ranking 93 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.39, which is -37.43% below the recent high of -1.50 and -249.80% above the recent low of -8.37.

Score

Industry at a Glance

Previous score
7.34
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 114/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Vivani Medical Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 4.00 and a low of 4.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
5.500
Target Price
+409.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

115
Total
6
Median
9
Average
Company name
Ratings
Analysts
Vivani Medical Inc
VANI
3
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Vivani Medical Inc is 6.45, ranking 126 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.18 and the support level at 0.93, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.43
Change
0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.015
Sell
RSI(14)
31.976
Neutral
STOCH(KDJ)(9,3,3)
11.113
Oversold
ATR(14)
0.070
High Vlolatility
CCI(14)
-199.699
Sell
Williams %R
96.000
Oversold
TRIX(12,20)
-0.449
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.106
Sell
MA10
1.144
Sell
MA20
1.152
Sell
MA50
1.256
Sell
MA100
1.315
Sell
MA200
1.348
Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Vivani Medical Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 4.73%, representing a quarter-over-quarter decrease of 29.21%. The largest institutional shareholder is The Vanguard, holding a total of 1.55M shares, representing 1.91% of shares outstanding, with 17.10% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Williams (Gregg)
18.29M
+0.58%
Bolck (Joachim Eberhard)
5.60M
--
Mendelsohn (Adam)
3.75M
+1.58%
The Vanguard Group, Inc.
Star Investors
1.34M
-6.32%
Mendelsohn (Aaron)
1.11M
+1.84%
Tanager Wealth Management LLP
1.02M
--
Geode Capital Management, L.L.C.
356.25K
+0.67%
Commonwealth Financial Network
330.53K
--
BlackRock Institutional Trust Company, N.A.
82.99K
+0.85%
1
2

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Vivani Medical Inc is 2.79, ranking 145 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
2.79
Change
0
Beta vs S&P 500 index
2.12
VaR
+6.92%
240-Day Maximum Drawdown
+45.45%
240-Day Volatility
+69.81%

Return

Best Daily Return
60 days
+11.03%
120 days
+14.19%
5 years
+270.30%
Worst Daily Return
60 days
-7.95%
120 days
-11.44%
5 years
-26.78%
Sharpe Ratio
60 days
-1.06
120 days
-0.90
5 years
-0.04

Risk Assessment

Maximum Drawdown
240 days
+45.45%
3 years
+77.25%
5 years
+96.02%
Return-to-Drawdown Ratio
240 days
--
3 years
-0.11
5 years
-0.20
Skewness
240 days
+1.10
3 years
+21.62
5 years
+22.20

Volatility

Realised Volatility
240 days
+69.81%
5 years
+117.90%
Standardised True Range
240 days
+7.80%
5 years
+19.91%
Downside Risk-Adjusted Return
120 days
-158.16%
240 days
-158.16%
Maximum Daily Upside Volatility
60 days
+55.87%
Maximum Daily Downside Volatility
60 days
+48.06%

Liquidity

Average Turnover Rate
60 days
+0.22%
120 days
+0.19%
5 years
--
Turnover Deviation
20 days
-80.39%
60 days
-80.03%
120 days
-83.24%

Peer Comparison

Healthcare Equipment & Supplies
Vivani Medical Inc
Vivani Medical Inc
VANI
5.99 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI